Concepedia

David H. Vesole

DH

137

Publications

17.4K

Citations

59

H-Index

1979

Active since

Affiliations

Hackensack University Medical Center(Current)

Medical College of Wisconsin

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Mayo Clinic

David H. Vesole is an author at Hackensack University Medical Center specializing in medicine, hematology, and transplantation.

ORCID

Top concepts

Publications per year

1979–2024

137

Publications

137

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan Bladé, Diana Samson, Donna Reece et al. · British Journal of Haematology · 1998 · 1.5K citations

Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

Andrew J. Ullmann, Jeffrey H. Lipton, David H. Vesole et al. · New England Journal of Medicine · 2007 · 1.3K citations · Full text

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

S. Vincent Rajkumar, Susanna Jacobus, Natalie S. Callander et al. · The Lancet Oncology · 2009 · 930 citations · Full text

, , +8

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Paul G. Richardson, Edie Weller, Sagar Lonial et al. · Blood · 2010 · 855 citations · Full text

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

J.-A. H. van Burik, V. Ratanatharathorn, Daniel E. Stepan et al. · Clinical Infectious Diseases · 2004 · 737 citations · Full text

Rows per page

1–5 of 137